Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 43 |
| Active Pipeline (Recruiting Now) | 22 (15) |
| Completed vs Stopped Early | 10 / 2 (4.7%) |
| Median Closed Actual Enrollment | 40 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| The Ottawa Hospital | Ottawa, Ontario | 22 |
| Jewish General Hospital | Montreal, Quebec | 2 |
| London Health Sciences Centre | London, Ontario | 2 |
Explore interactive annual charts and M&A subsidiary rollups in the Ottawa Hospital Research Institute Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.